MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Device Alarm System (1012)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/31/2022 |
Event Type
malfunction
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider, foreign) regarding a patient who w as receiving fentanyl (450.0 mcg/ml at 450.55 mcg/day) and bupivacaine (15.0 mg/ml at 15.018 mg/day) via an implantable pump for unknown indications for use.It was reported that the pump had gone below the reservoir threshold and was beeping (alarming) to indicate a low reservoir, following the refill that day.As per the logs, a non-critical low reservoir alarm occurred on (b)(6) 2022.After filling, the nurse reprogrammed the pump, and the pump beeped continuously for a few seconds.Pump interrogation was performed.The nurse looked in the pump's logs and nothing was noted.Factors that may have led or contributed to the issue were unknown.No surgical intervention occurred and no surgical intervention was planned.The issue was resolved.The patient was without injury regarding their status as of (b)(6) 2022.The patient's medical history and weight at the time of the event was unknown or would not be made available.Additional information was later received from a company representative on (b)(6) 2022.It was clarified that the nurse had not silenced the non-critical alarm.The patient / nurse had not heard the beep again.The nurse confirmed that the beeping came from the pump and not the communicator.There were no other pumps present in the room.After the beep was heard, the pump was re-interrogated when the reservoir was full (40 ml).There was no alarm then in progress.The patient¿s medical history, age, and weight at the time of the event was unknown or would not be made available.
|
|
Manufacturer Narrative
|
This regulatory report is being submitted as part of a retrospective review as part of remediation plan 411.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|